Explore the words cloud of the CANCERPREV project. It provides you a very rough idea of what is the project "CANCERPREV" about.
The following table provides information about the project.
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE
|Coordinator Country||Switzerland [CH]|
|Total cost||4˙096˙014 €|
|EC max contribution||4˙096˙014 € (100%)|
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
|Duration (year-month-day)||from 2019-11-01 to 2023-10-31|
Take a look of project's partnership.
|1||ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE||CH (LAUSANNE)||coordinator||843˙829.00|
|2||KAROLINSKA INSTITUTET||SE (STOCKHOLM)||participant||563˙965.00|
|3||UNIVERSITE DE LAUSANNE||CH (LAUSANNE)||participant||562˙553.00|
|4||HELSINGIN YLIOPISTO||FI (HELSINGIN YLIOPISTO)||participant||561˙611.00|
|5||MEDIZINISCHE UNIVERSITAET WIEN||AT (WIEN)||participant||528˙414.00|
|6||FONDAZIONE EDO ED ELVO TEMPIA VALENTA - ONLUS||IT (BIELLA)||participant||522˙999.00|
|7||VIB VZW||BE (ZWIJNAARDE - GENT)||participant||512˙640.00|
Incidence and prevalence of many cancer types are significantly increasing worldwide, with substantial differences between the sexes. Environmental influences in concert with genetic and epigenetic factors are still poorly understood. Simultaneously, more sophisticated and expensive treatments cannot be afforded by society, increasing urgency of efforts in cancer prevention. CANCERPREV is an innovative interdisciplinary research and training program gathering seven academic beneficiaries and nine partner organizations : (one leading pharmaceutical company, one leading technology company, a health insurance, an internationally known nursing school, three foundations and two universities) in nine European countries. CANCERPREV aims to establish new strategies in cancer prevention, with a focus on two key determinants of cancer risk: sex hormone signaling and chronic inflammation, in breast and skin as benchmarks of early steps of cancer development in organs with reproductive and non-reproductive functions, respectively. Fifteen Early Stage Researchers (ESRs) will benefit from the complementary expertise of participating organizations and Principal Investigators in: basic cancer research, xenografts and genetic mouse models, bioinformatics and mathematical algorithms, epidemiology / human genetics, biomarkers, pharmacological approaches, behavioral / societal issues and outreach. This network provides ESRs with unique future career opportunities in both academic and private sectors, through research training for PhD thesis projects with secondments and short and long visits to other participating research institutions, and yearly courses / formal lectures on various aspects of cancer prevention, including global health and occupational / behavioral issues. CANCERPREV will ensure that more knowledge and ideas are converted into products and services, and that a new generation of scientists is trained to contribute to the knowledge-based economy and society.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CANCERPREV" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CANCERPREV" are provided by the European Opendata Portal: CORDIS opendata.